Skip to main content

Published locations for LOXO-305: Next-gen BTK inhibitor safe and effective in B-cell malignancies

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. LOXO-305: Next-gen BTK inhibitor safe and effective in B-cell malignancies

User login

  • Reset your password
  • /content/loxo-305-next-gen-btk-inhibitor-safe-and-effective-b-cell-malignancies
  • /hematologynews/article/214676/mantle-cell-lymphoma/loxo-305-next-gen-btk-inhibitor-safe-and
  • /oncologypractice/article/214676/mantle-cell-lymphoma/loxo-305-next-gen-btk-inhibitor-safe-and
  • /hematology-oncology/article/214676/mantle-cell-lymphoma/loxo-305-next-gen-btk-inhibitor-safe-and
  • /b-cell-lymphoma-icymi/article/214676/mantle-cell-lymphoma/loxo-305-next-gen-btk-inhibitor-safe-and